Claroid Pharmaceuticals Limited, a active public limited company, was established on 31 August 2018 in Daskroi, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304GJ2018PTC103796. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹15.00 Cr.
Employing 31 professional, Its leadership includes Rushin Baijubhai Desai (Whole-Time Director), Arpankumar Patel (Director), Ghanshyam Arjanbhai Patel (Director). Past directors included Rushin Baijubhai Desai, Arpankumar Patel, Ghanshyam Arjanbhai Patel. It holds ₹33.83 Cr open charges and no settled loans. Its latest AGM occurred on 31 July 2025, with the balance sheet filed on 31 March 2025. It is based at S.No-217/P, Opp Gurukul English School,, Kamod-Pirana Road,, Daskroi, Gujarat, 382425.
U24304GJ2018PLC103796
103796
31 August 2018
₹25.00 Cr
₹15.00 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Claroid Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rushin Baijubhai Desai | Whole-Time Director | 31 Aug 2018 | Current |
| Arpankumar Patel | Director | 28 Apr 2025 | Current |
| Ghanshyam Arjanbhai Patel | Director | 31 Aug 2018 | Current |
| Snehalkumar Hasmukhlal Soni | Whole-Time Director | 31 Aug 2018 | Current |
| Shailesh Arjanbhai Patel | Whole-Time Director | 31 Aug 2018 | Current |
| Shashwat Yatishkumar Shah | Director | 28 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 May 2025 | Past |
| Pramod Abcsdd | Additional Director | 30 Jul 2025 | Past |
| Pramod Abcsdd | Director | 19 May 2025 | Past |
| Pramod Abcsdd | Director | 19 May 2025 | Past |
| Pramod Abcsdd | Director | 19 May 2025 | Past |
| Pramod Abcsdd | Director | 01 Apr 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Claroid Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹338,328,042.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Feb 2020 | Hdfc Bank Limited | ₹33.83 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Claroid Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Claroid Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Claroid Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Megha Parikh was appointed as a Company Secretary was appointed as a Company Secretary on 02 Aug 2025 & has been associated with this company since 4 months 20 days . was documented.
The activity Claroid Pharmaceuticals Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records. was completed.
Baiju Bhupendrabhai Desai was appointed as a Cfo was appointed as a Cfo on 19 Jun 2025 & has been associated with this company since 6 months 3 days . was recorded as a recent event.
Baiju Bhupendrabhai Desai was appointed as a CFO was appointed as a CFO on 20 May 2025 & has been associated with this company since 7 months 2 days . was recorded as a recent event.
The activity Arpankumar Patel was appointed as a Director was appointed as a Director on 28 Apr 2025 & has been associated with this company since 7 months 24 days . was completed.
Progress on Shashwat Yatishkumar Shah was appointed as a Director was appointed as a Director on 28 Apr 2025 & has been associated with this company since 7 months 24 days . was documented.
The CIN of Claroid Pharmaceuticals Limited is U24304GJ2018PLC103796.
Claroid Pharmaceuticals Limited is headquartered at S.No-217/P, Opp Gurukul English School,, Kamod-Pirana Road,, Daskroi, Gujarat, 382425.
Claroid Pharmaceuticals Limited was incorporated on 31 August 2018.
The current directors of Claroid Pharmaceuticals Limited are
The primary industry of Claroid Pharmaceuticals Limited is Manufacturing.
Claroid Pharmaceuticals Limited is unlisted.
The authorized capital of Claroid Pharmaceuticals Limited is ₹25.00 Cr, and the paid-up capital is ₹15.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX